Literature DB >> 25938038

Comparison of pre-treatment and post-treatment use of selenium in retinal ischemia reperfusion injury.

Alper Yazici1, Hasan Aksit2, Esin Sogutlu Sari1, Arzu Yay3, Haydar Ali Erken4, Dilek Aksit5, Harun Cakmak6, Kamil Seyrek7, Sitki Samet Ermis1.   

Abstract

AIM: To investigate the effects of selenium in rat retinal ischemia reperfusion (IR) model and compare pre-treatment and post-treatment use.
METHODS: Selenium pre-treatment group (n=8) was treated with intraperitoneal (i.p.) selenium 0.5 mg/kg for 7d and terminated 24h after the IR injury. Selenium post-treatment group (n=8) was treated with i.p. selenium 0.5 mg/kg for 7d after the IR injury with termination at the end of the 7d period. Sham group (n=8) received i.p. saline injections identical to the selenium volume for 7d with termination 24h after the IR injury. Control group (n=8) received no intervention. Main outcome measures were retina superoxide dismutase (SOD), glutathione (GSH), total antioxidant status (TAS), malondialdehyde (MDA), DNA fragmentation levels, and immunohistological apoptosis evaluation.
RESULTS: Compared to the Sham group, selenium pre-treatment had a statistical difference in all parameters except SOD. Post-treatment selenium also resulted in statistical differences in all parameters except the MDA levels. When comparing selenium groups, the pre-treatment selenium group had a statistically higher success in reduction of markers of cell damage such as MDA and DNA fragmentation. In contrast, the post-selenium treatment group had resulted in statistically higher levels of GSH. Histologically both selenium groups succeeded to limit retinal thickening and apoptosis. Pre-treatment use was statistically more successful in decreasing apoptosis in ganglion cell layer compared to post-treatment use.
CONCLUSION: Selenium was successful in retinal protection in IR injuries. Pre-treatment efficacy was superior in terms of prevention of tissue damage and apoptosis.

Entities:  

Keywords:  apoptosis; ischemia-reperfusion; oxidative stress; post-treatment; pre-treatment; retina; selenium

Year:  2015        PMID: 25938038      PMCID: PMC4413567          DOI: 10.3980/j.issn.2222-3959.2015.02.09

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  30 in total

1.  Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation.

Authors:  W A Pryor; J P Stanley
Journal:  J Org Chem       Date:  1975-11-28       Impact factor: 4.354

2.  The neuroprotective effect of carnosine (β-alanyl-L-histidine) on retinal ganglion cell following ischemia-reperfusion injury.

Authors:  Yong-Sok Ji; Jung-Won Park; Hwan Heo; Jong-Seong Park; Sang-Woo Park
Journal:  Curr Eye Res       Date:  2013-11-08       Impact factor: 2.424

3.  Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus.

Authors:  Seema Yousuf; Fahim Atif; Muzamil Ahmad; Md Nasrul Hoda; M Badruzzaman Khan; Tauheed Ishrat; Fakhrul Islam
Journal:  Brain Res       Date:  2007-02-17       Impact factor: 3.252

4.  Effect of trimetazidine on retinal ischemia/reperfusion injury in rats.

Authors:  S Ozden; B Kildaci; S Muftuoglu; N Cakar; C Yildirim
Journal:  Ophthalmologica       Date:  2001 Jul-Aug       Impact factor: 3.250

5.  Retinal glutamate in diabetes and effect of antioxidants.

Authors:  R A Kowluru; R L Engerman; G L Case; T S Kern
Journal:  Neurochem Int       Date:  2001-04       Impact factor: 3.921

6.  Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.

Authors:  Kouki Fukuda; Kazuyuki Hirooka; Masanori Mizote; Takehiro Nakamura; Toshifumi Itano; Fumio Shiraga
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

Review 7.  Oxidative stress as a mediator of cardiovascular disease.

Authors:  Maqsood M Elahi; Yu Xiang Kong; Bashir M Matata
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

8.  Nonsynergistic effects of trimetazidine and selenium combination therapy on renal ischemic-reperfusion injury in rats.

Authors:  Ibrahim Karayaylali; Mustafa Emre; Neslihan Seyrek; Sule Menziletoglu Yildiz; Seyda Erdogan; Mustafa Balal; Saime Paydas; Ilhan Tuncer; Nazan Alparslan
Journal:  Adv Ther       Date:  2004 Jan-Feb       Impact factor: 3.845

9.  The effects of selenium against cerebral ischemia-reperfusion injury in rats.

Authors:  Seda Ozbal; Güven Erbil; Hilal Koçdor; Kazim Tuğyan; Cetin Pekçetin; Candan Ozoğul
Journal:  Neurosci Lett       Date:  2008-04-04       Impact factor: 3.046

10.  Selenium protects the immature rat heart against ischemia/reperfusion injury.

Authors:  Ivana Ostadalova; Miloslav Vobecky; Zuzana Chvojkova; Dana Mikova; Vaclav Hampl; Jiri Wilhelm; Bohuslav Ostadal
Journal:  Mol Cell Biochem       Date:  2006-12-23       Impact factor: 3.842

View more
  3 in total

1.  Involvement of TRPM2 Channel on Hypoxia-Induced Oxidative Injury, Inflammation, and Cell Death in Retinal Pigment Epithelial Cells: Modulator Action of Selenium Nanoparticles.

Authors:  Dilek Özkaya; Mustafa Nazıroğlu; László Vanyorek; Salina Muhamad
Journal:  Biol Trace Elem Res       Date:  2021-01-02       Impact factor: 3.738

2.  Selenium Alleviates Cerebral Ischemia/Reperfusion Injury by Regulating Oxidative Stress, Mitochondrial Fusion and Ferroptosis.

Authors:  Lijian Han; Yuanyuan Shi; Xianxian Zhang; Lili Xie; Pinglei Pan; Fei Chen
Journal:  Neurochem Res       Date:  2022-06-20       Impact factor: 4.414

3.  Protective Effect of SeMet on Liver Injury Induced by Ochratoxin A in Rabbits.

Authors:  Ziqiang Zhang; Jingyi Xu; Xin Zhang; Jiajia Wang; Hui Xie; Yingying Sun; Qianwen Zhang; Zhaoyang Chang; Yumei Liu
Journal:  Toxins (Basel)       Date:  2022-09-08       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.